Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Acute Coronary Syndrome Exclusion Using the Beckman Coulter Access High-sensitivity I Troponin

NCT04488913 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT04488913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04488913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Acute Coronary Syndrome Exclusion Using the Beckman Coulter Access High-sensitivity I Troponin
Lead sponsor
Henry Ford Health System
Phase
Not applicable
Overall status
Completed
Start date
July 29, 2020
Completion date
March 3, 2022
Enrollment
32,609 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chest pain, myocardial ischemia